Abstract
Tumor-induced osteomalacia (TIO) is a paraneoplastic bone mineral disturbance related to fibroblast growth factor 23 (FGF23) overproduction by the tumor, usually from mesenchymal origin. Such condition leads to high phosphate renal wasting and, consequently, to cumbersome symptoms as weakness, bone pain, and fractures. Case report. We report a case of an advanced castration-refractory prostate cancer patient, which developed severe hypophosphatemia with elevated phosphate excretion fraction. TIO was suspected, and increased levels of FGF23 reinforced such diagnosis. The patient died 4 months after being diagnosed with TIO. This case suggests that TIO has a dismal prognosis in prostate cancer patients. The clinical oncology community must be aware about such disturbance that can be present in those patients with weakness, bone pain, and hypophosphatemia.
References
Jun 1, 1975·The British Journal of Radiology·D J HoskingW R Shortland-Webb
May 1, 1995·The Journal of Clinical Endocrinology and Metabolism·G E WilkinsG P Bondy
Apr 25, 2003·The New England Journal of Medicine·Kenneth B JonssonHarald Jüppner
Jun 3, 2004·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Jan 25, 2005·Bone·Rob C M PelgerNeveen A T Hamdy
May 24, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paranee AuethavekiatJeffrey L Berenberg
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert E Coleman
Nov 27, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Casey L Cotant, Panduranga S Rao
Mar 1, 2011·Lancet·Karim FizaziCarsten Goessl
Apr 15, 2011·Endocrine-related Cancer·William H ChongMichael T Collins
Citations
Feb 9, 2013·The Journal of Clinical Endocrinology and Metabolism·David E LeafHarald Jüppner
Jun 14, 2013·Nutrients·Vickram Tejwani, Qi Qian
Jan 10, 2014·Skeletal Radiology·Monica C KoplasMurali Sundaram
Sep 21, 2015·Annals of Diagnostic Pathology·Arturo Angeles-AngelesBraulio Martinez-Benitez
Feb 18, 2014·Clinical Endocrinology·Swati JadhavNalini S Shah
Aug 27, 2014·Medical Hypotheses·Esther K LeeUrban Emmenegger
Dec 12, 2012·Bone·P ChiamM Chandran
Mar 28, 2017·Endocrine-related Cancer·Georgios K DimitriadisAshley Grossman
Nov 28, 2015·International Journal of Surgical Pathology·Adrienne SauderDonghong Cai
Jan 31, 2018·Endocrine Reviews·Yuka Kinoshita, Seiji Fukumoto
Mar 13, 2019·Head & Neck·Rishabh P AcharyaRobert F Gagel
Jun 25, 2014·The Journal of Clinical Endocrinology and Metabolism·Swati JadhavNalini S Shah
Jul 14, 2017·Nature Reviews. Disease Primers·Salvatore MinisolaMichael T Collins
Jul 6, 2019·Journal of Diabetes and Metabolic Disorders·Constantinos SavvaKamal Chokkalingam
Jun 7, 2020·Calcified Tissue International·Pablo FlorenzanoMichael T Collins
May 29, 2015·Oncotarget·Shu FengMichael Ittmann
Jul 1, 2017·Endocrine·Francesco MinisolaJessica Pepe
Jul 19, 2019·BMJ Case Reports·Awo Akosua K LaymanSanjeev Shah
Feb 15, 2021·Annals of Nuclear Medicine·Ayako KatoKaori Togashi
Jun 21, 2021·Bone·Maria Luisa BrandiLothar Seefried
Jul 14, 2021·Journal of Bone and Mineral Metabolism·Nobuaki ItoSeiji Fukumoto